Selective increase of α(2A)-adrenoceptor agonist binding sites in brains of depressed suicide victims

Journal of Neurochemistry

Volumn 70, Issue 3, 1998, Pages 1114-1123

  Callado, Luis F ^a   Meana, J Javier ^a   Grijalba, Bernardo ^b   Pazos, Angel ^b   Sastre, Magdalena ^c   García Sevilla, Jesús A ^c  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b UNIVERSITY OF CANTABRIA   (Spain)

^c UNIVERSITAT DE LES ILLES BALEARS   (Spain)

Author keywords

Depression; Frontal cortex; Human brain; Suicide; 2 Adrenoceptor subtypes

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; RECEPTOR SUBTYPE; 2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; 2-METHOXYIDAZOXAN; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BRIMONIDINE; CLONIDINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; IDAZOXAN; QUINOXALINE DERIVATIVE; TRITIUM;

ADULT; ARTICLE; AUTOPSY; AUTORADIOGRAPHY; BRAIN REGION; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; HUMAN TISSUE; LIGAND BINDING; MALE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DETERMINATION; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR DENSITY; SUICIDE; BINDING COMPETITION; BRAIN LEVEL; CELL MEMBRANE; CHEMISTRY; FRONTAL LOBE; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ADULT; AUTORADIOGRAPHY; BINDING, COMPETITIVE; BRAIN CHEMISTRY; CELL MEMBRANE; CLONIDINE; DEPRESSION; FEMALE; FRONTAL LOBE; HUMANS; IDAZOXAN; MALE; MIDDLE AGED; QUINOXALINES; RECEPTORS, ADRENERGIC, ALPHA-2; SUICIDE; TRITIUM;

EID: 0031594755     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.70031114.x     Document Type: Article

References (56)

1. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders, 3rd edit., revised. American Psychiatric Association, Washington, D.C.
2. 2-adrenergic receptors in the cerebral cortex of controls and suicide victims. Brain Res. 630, 271-282.
3. 3H]rauwolscine. Eur. J. Pharmacol. 106, 141-147.
4. Bremner J. D. (1995) A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression. J. Clin. Psychiatry 56, 519-525.
5. Bylund D. B. (1985) Heterogeneity of alpha-2 adrenergic receptors. Pharmacol. Biochem. Behav. 22, 835-843.
6. 2-adrenergic receptors. FASEB J. 6, 832-839.
7. Bylund D. B., Ray-Prenger C., and Murphy T. J. (1988) Alpha-2A and alpha-2B adrenergic receptor subtypes: antagonist binding in tissues and cell lines containing only one subtype. J. Pharmacol. Exp. Ther. 245, 600-607.
8. Caldecott-Hazard S., Morgan D. G., DeLeon-Jones F., Overstreet D. H., and Janowsky D. (1991) Clinical and biochemical aspects of depressive disorders. II. Transmitter/receptor theories. Synapse 9, 251-301.
9. 2B/C-adrenoceptor subtypes in human brain and rat kidney. Eur. J. Pharmacol. 332, 109-112.
10. Cheetham S. C., Katona C. L. E., and Horton R. W. (1991) Postmortem studies of neurotransmitter biochemistry in depression and suicide, in Biological Aspects of Affective Disorders (Horton R. and Katona C., eds), pp. 191-221. Academic Press, London.
11. Claghorn J. L. and Lesen M. D. (1995) A double-blind placebo-controlled study of Org 3770 in depressed outpatients. J. Affect. Disord. 34, 165-171.
12. Crow T. J., Cross A. J., Cooper S. J., Deakin J. F. W., Ferner I. N., Johnson J. A., Joseph M. H., Owen F., Poulter M., Lofthouse R., Corsellis J. A. N., Chambers D. R., Blessed G., Perry E. K., Perry R. H., and Tomlinson B. E. (1984) Neurotransmitter receptors and monoamine metabolites in the brain of patients with Alzheimer-type dementia and depression, and suicides. Neuropharmacology 23, 1561-1569.
13. De Paermentier F., Mauger J. M., Lowther S., Crompton M. R., Katona C. L. E., and Horton R. W. (1997) Brain α-adrenoceptors in depressed suicides. Brain Res. 757, 60-68.
14. 2B-adreno-ceptor subtypes in postmortem human brain. J. Neurochem. 58, 1555-1560.
15. 2-adrenoceptor binding in elderly depressed patients. Am. J. Psychiatry 142, 1489-1490.
16. 2-adrenoceptor subtypes. Naunyn Schmiedebergs Arch. Pharmacol. 353, 391-399.
17. Ferner I. N., McKeith I. G., Cross A. J., Perry E. K., Candy J. M., and Perry R. H. (1986) Postmortem neurochemical studies in depression. Ann. NY Acad. Sci. 487, 128-142.
18. 2-adrenergic receptors in major depressive disorder. Binding of tritiated clonidine before and after tricyclic antidepressant drug treatment. Arch. Gen. Psychiatry 38, 1327-1333.
19. 2-adrenoceptors in major affective disorder. Arch. Gen. Psychiatry 43, 51-57.
20. 3H] (-) adrenaline to platelets of depressed patients with melancholia: effect of long-term clomipramine treatment. Acta Psychiatr. Scand. 75, 150-157.
21. 2-Adrenoceptor-mediated inhibition of platelet adenylate cyclase and induction of aggregation in major depression. Effect of long-term cyclic antidepressant drug treatment. Arch. Gen. Psychiatry 47, 125-132.
22. 2-adrenoceptors after manipulation of noradrenergic transmission in the rat. Eur. J. Pharmacol. 164, 455-466.
23. 2-adrenoceptor agonist binding sites in the hippocampus and frontal cortex of depressed suicide victims. J. Neurochem. 63, 256-265.
24. Göthert M. and Huth H. (1980) Alpha-adrenoceptor-mediated modulation of 5-hydroxytryptamine release from rat brain cortex slices. Naunyn Schmiedebergs Arch. Pharmacol. 313, 21-26.
25. 3H]RX821002 binding to membranes and tissue sections. Eur. J. Pharmacol. 310, 83-93.
26. 2-adrenoceptor desensitization by desipramine and ECS. Br. J. Pharmacol 103, 1865-1870.
27. 2-adrenergic receptors in depression. Psychiatry Res. 43, 243-252.
28. Karege F., Bovier P., Rudolph W., and Gaillard J-M. (1996) Platelet phosphoinositide signaling system: an overstimulated pathway in depression. Biol. Psychiatry 39, 697-702.
29. Lowry O. H., Rosebrough N. J., Farr A. L., and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
30. McPherson G. A. (1985) Analysis of radioligand binding experiments: a collection of computer programs for IBM PC. J. Pharmacol. Methods 14, 213-228.
31. 2-adrenoceptor density in the frontal cortex of depressed suicide victims. J. Neural Transm. 70, 377-381.
32. 3H]UK 14304. J. Neurochem. 52, 1210-1217.
33. 2-Adrenoceptors in the brain of suicide victims: increased receptor density associated with major depression. Biol. Psychiatry 31, 471-490.
34. 1A receptors in the rat brain. Eur. J. Pharmacol. 312, 385-388.
35. 2-adrenoceptors mediating mydriasis in the rat. Naunyn Schmiedebergs Arch. Pharmacol. 341, 101-107.
36. 2-adrenoceptors on serotonin terminals following long-term treatment with drugs increasing norepinephrine synaptic concentration. Neuropsychopharmacology 10, 41-51.
37. Munson P. J. and Rodbard D. (1980) LIGAND: a versatile computerized approach for characterization of ligand binding system. Anal. Biochem. 107, 220-239.
38. 2-adrenoceptor-mediated inhibition of cyclic AMP production in rat brain cerebral cortical slices. Brain Res. 410, 195-198.
39. Ordway G. A., Jaconetta S. M., and Halaris A. (1993) Characterization of subtypes of alpha-2 adrenoceptors in the human brain. J. Pharmacol. Exp. Ther. 264, 967-976.
40. 2-adrenoceptors is elevated in the locus coeruleus from victims of suicide. J. Neurochem. 63, 617-624.
41. 3H-clonidine binding in the platelets of patients with depressive and schizophrenic disorders. Psychiatry Res. 28, 73-88.
42. 2-adrenergic receptor subtype mRNAs in human tissues. Mol. Brain Res. 16, 57-63.
43. 3H]yohimbine binding in human brain. Life Sci. 38, 2129-2137.
44. 3H]-paraaminoclonidine binding to platelet adrenoceptor in depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 12, 541-553.
45. 2-adrenergic receptors: implications for depression. Crit. Rev. Neurobiol. 9, 29-66.
46. 2-adrenoceptors in depressive illness. Life Sci. 39, 1589-1616.
47. 3H-para-amino-clonidine binding to platelet purified plasma membranes from depressed patients. Neuropsychopharmacology 3, 201-210.
48. Piletz J. E., Halaris A., Saran A., and Marier M. R. (1991) Desipramine lowers tritiated para-aminoclonidine binding in platelets of depressed patients. Arch. Gen. Psychiatry 48, 813-820.
49. 1-imidazoline binding sites are elevated in depression but not generalized anxiety disorder. J. Psychiatry Res. 30, 147-168.
50. 2A subtype. J. Neurochem. 63, 1077-1085.
51. i proteins in the human brain: ratio of high-affinity agonist sites to antagonist sites and effect of age. J. Pharmacol. Exp. Ther. 269, 1062-1072.
52. 2-Adrenoreceptors in rat brain are decreased after long-term tricyclic antidepressant drug treatment. Brain Res. 210, 413-418.
53. Starke K. and Montel H. (1973) Alpha-receptor-mediated modulation of transmitter release from central noradrenergic neurons. Naunyn Schmiedebergs Arch. Pharmacol. 279, 53-60.
54. Svensson T. H., Bunney B. S., and Aghajanian G. K. (1975) Inhibition of both noradrenergic and serotonergic neurones in the brain by the α-adrenergic agonist clonidine. Brain Res. 92, 291-306.
55. 2adrenoceptor subtypes. Br. J. Pharmacol. 119, 358P.
56. 3H]idazoxan. Neurochem. Int. 17, 537-546.